Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;54(3):234-41.
doi: 10.1016/j.bcmd.2014.12.005. Epub 2015 Jan 15.

Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis

Fiorella Ciaffoni  1 , Elena Cassella  2 , Lilian Varricchio  2 , Margherita Massa  3 , Giovanni Barosi  4 , Anna Rita Migliaccio  5
Affiliations

Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis

Fiorella Ciaffoni et al. Blood Cells Mol Dis. 2015 Mar.

Abstract

Primary myelofibrosis (PMF) is characterized by megakaryocyte hyperplasia, dysplasia and death with progressive reticulin/collagen fibrosis in marrow and hematopoiesis in extramedullary sites. The mechanism of fibrosis was investigated by comparing TGF-β1 signaling of marrow and spleen of patients with PMF and of non-diseased individuals. Expression of 39 (23 up-regulated and 16 down-regulated) and 38 (8 up-regulated and 30 down-regulated) TGF-β1 signaling genes was altered in the marrow and spleen of PMF patients, respectively. Abnormalities included genes of TGF-β1 signaling, cell cycling and abnormal in chronic myeloid leukemia (EVI1 and p21(CIP)) (both marrow and spleen) and Hedgehog (marrow only) and p53 (spleen only) signaling. Pathway analyses of these alterations predict an increased osteoblast differentiation, ineffective hematopoiesis and fibrosis driven by non-canonical TGF-β1 signaling in marrow and increased proliferation and defective DNA repair in spleen. Since activation of non-canonical TGF-β1 signaling is associated with fibrosis in autoimmune diseases, the hypothesis that fibrosis in PMF results from an autoimmune process triggered by dead megakaryocytes was tested by determining that PMF patients expressed plasma levels of mitochondrial DNA and anti-mitochondrial antibodies greater than normal controls. These data identify autoimmunity as a possible cause of marrow fibrosis in PMF.

Keywords: Autoimmunity; Inflammation; Myelofibrosis; TGF-β1.

PubMed Disclaimer

Conflict of interest statement

AUTHORSHIP AND CONFLICT OF INTEREST STATEMENTS

Fiorella Ciaffoni, Elena Cassella and Margherita Massa performed experiments and analyzed data.

Giovanni Barosi provided samples from PMF patients and normal donors and assured compliance of the study with institutional IRB.

Anna Rita Migliaccio, Lilian Varricchio and Giovanni Barosi designed research, analyzed the data and wrote the manuscript.

All the authors have read the manuscript, concur with its content and state that its content has not been submitted elsewhere.

CONFLICT OF INTEREST DISCLOSURE: FC, EC, LV, MM, GB, and ARM declare no competing financial interest.

Figures

Figure 1
Figure 1. The bone marrow and spleen of PMF patients present unique alteration signatures of TGF-β signalling
Hierarchical clustering of normalized gene expression in bone marrow and spleen from non-diseased volunteers (controls, C, n=3) and PMF patients. Results were obtained with BM from three JAK2V617F-mutated PMF patients and spleen from four JAK2V617F-mutated (in black) and two JAK2V617F-mutated PMF patients.
Figure 2
Figure 2. Quantitative RT-PCR validation that the alteration signatures of bone marrow and spleen of PMF patients predict activation of non-canonical (up-regulation of JUN, GADD45B, EVI1 and STAT1) rather than canonical (down-regulation of BMP4, BMP7, SMAD7, STAT1, and up-regulation of COL1A1), TGF-β signaling
Results are expressed in relative units considering the expression in the corresponding organs from non diseased volunteers (Ctrl) as 1 and are presented as mean (±SD) of values observed with BM from three PMF patients and three non-diseased individuals and with spleen from five PMF patients and three non-diseased individuals (the same samples analyzed in Figure 1). To allow appreciation of the difference in gene expression between BM and spleen, Figure S1 presents results from both BM and spleen expressed in relative units considering values in BM from non diseased volunteers as 1.
Figure 3
Figure 3. Plasma from PMF patients contains levels greater than normal of cell-free mitochondrial DNA (A) and anti-mitochondrial antibodies (B) and normal levels of antinuclear antibodies (C)
Results are expressed as individual values (symbols) and as mean (±SD) of values (columns) from non-diseased volunteers (Ctrl), essential thrombocythemia (ET) and primary myelofibrosis (PMF) patients. The same individuals were analyzed in A–C. The numbers of individuals included in each cohort is indicated in parenthesis. The yellow area in C indicates the range of optical density observed in the standards provided by the Kit as negative controls. See Material and Methods for further details.
Figure 4
Figure 4. A model for establishment of the autoimmune process possibly leading to fibrosis in PMF
Neutrophils presenting extracellular traps (NET) of autologous DNA trigger autoimmune reactions resulting in fibrosis in cystic fibrosis (Reviewed in ref 33). Using this mechanism as a foundation, we propose here that NET formed by mitochondrial DNA released by MK dying of para-apoptosis during the process of pathological emperipolesis with neutrophils (refs 10, 34, 35) may trigger the autoimmune reaction leading to fibrosis in PMF. Legend: Neu = neutrophil; MK = megakaryocyte; nu = para-apoptotic nucleus; mDNA = mitochondrial DNA.
See this image and copyright information in PMC

References

    1. Ghosh AK, Quaggin SE, Vaughan DE. Molecular basis of organ fibrosis: potential therapeutic approaches. Exp Biol Med (Maywood) 2013;238:461–481. - PubMed
    1. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295–309. - PubMed
    1. Kinoshita K, Iimuro Y, Otogawa K, Saika S, Inagaki Y, Nakajima Y, Kawada N, Fujimoto J, Friedman SL, Ikeda K. Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut. 2007;56:706–714. - PMC - PubMed
    1. Fukasawa H, Yamamoto T, Togawa A, Ohashi N, Fujigaki Y, Oda T, Uchida C, Kitagawa K, Hattori T, Suzuki S, Kitagawa M, Hishida A. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A. 2004;101:8687–8692. - PMC - PubMed
    1. Liu GX, Li YQ, Huang XR, Wei L, Chen HY, Shi YJ, Heuchel RL, Lan HY. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-beta/Smad3-NF.kappaB-dependent mechanisms in mice. PLoS One. 2013;8:e53573. - PMC - PubMed

Publication types

Substances